|
TestoFEN is the first product ever designed which can stimulate the body’s own production of Androgens to increase muscularity, strength and increased sex drive! By stimulating the Adrenal cortex TestoFEN causes the release of the body’s own muscle building factory, Androgens! The most common of these androgens produced you may have already heard of, Androstenedione! Yes, TestoFEN causes your body to produce its own Androstenedione! Lets see the Feds try to arrest you for that!
|
You already know that taking a multivitamin every day is a smart choice. That's why Anabolic VITAKIC is designed to deliver a cutting-edge micronutrient multivitamin complex specifically for hard-training bodybuilders. This complex includes multiple key micronutrients that protect cells from the damage caused by unstable molecules known as free radicals, making it extremely beneficial to bodybuilders. In addition, Anabolic VITAKIC is dosed with a key musclebuilding compound, forging the foundation for explosive muscle growth!
|
ANABOL 5 is the world’s strongest non-steroidal anabolic agent. By creating a highly anabolic and anti-catabolic environment ANABOL 5 dramatically increases the amount of protein a muscle can synthesize. When used in combination with intense weight training the pronounced adaptogenic properties of ANABOL 5 stimulate overall anabolism, block the breakdown of muscle protein and combat muscular fatigue.
|
Now, no doubt, since this anabolic does not fall into the category of recently banned synthetic prohormones, it’s legal to posses in the United States. And because it’s not currently being submitted for drug approval in the U.S. it’s legal to sell over the counter! After a period of negotiation over a 6-month period, IDS has obtained 17 Hydroxy-MESTERONE to succeed the Methyl 1 Test Xtreme as the premier Testosterone based mass builder in the IDS lineup. Please understand, quantities of 17 Hydroxy-MESTERONE are extremely limited and due to the dramatic results of just a few weeks use, the demand will be tremendous.
|
